Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2010 1
2011 1
2012 5
2014 1
2015 2
2017 1
2018 1
2019 4
2020 1
2021 7
2022 12
2023 10
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

50 results

Results by year

Filters applied: . Clear all
Page 1
Neurotransmitter signaling: a new frontier in colorectal cancer biology and treatment.
Battaglin F, Jayachandran P, Strelez C, Lenz A, Algaze S, Soni S, Lo JH, Yang Y, Millstein J, Zhang W, Roussos Torres ET, Shih JC, Mumenthaler SM, Neman J, Lenz HJ. Battaglin F, et al. Among authors: jayachandran p. Oncogene. 2022 Oct;41(43):4769-4778. doi: 10.1038/s41388-022-02479-4. Epub 2022 Oct 1. Oncogene. 2022. PMID: 36182970 Free PMC article. Review.
Ascites and resistance to immune checkpoint inhibition in dMMR/MSI-H metastatic colorectal and gastric cancers.
Fucà G, Cohen R, Lonardi S, Shitara K, Elez ME, Fakih M, Chao J, Klempner SJ, Emmett M, Jayachandran P, Bergamo F, García MD, Mazzoli G, Provenzano L, Colle R, Svrcek M, Ambrosini M, Randon G, Shah AT, Salati M, Fenocchio E, Salvatore L, Chida K, Kawazoe A, Conca V, Curigliano G, Corti F, Cremolini C, Overman M, Andre T, Pietrantonio F. Fucà G, et al. Among authors: jayachandran p. J Immunother Cancer. 2022 Feb;10(2):e004001. doi: 10.1136/jitc-2021-004001. J Immunother Cancer. 2022. PMID: 35110358 Free PMC article.
Subcutaneous Administration of Monoclonal Antibodies: Pharmacology, Delivery, Immunogenicity, and Learnings From Applications to Clinical Development.
Davis JD, Bravo Padros M, Conrado DJ, Ganguly S, Guan X, Hassan HE, Hazra A, Irvin SC, Jayachandran P, Kosloski MP, Lin KJ, Mukherjee K, Paccaly A, Papachristos A, Partridge MA, Prabhu S, Visich J, Welf ES, Xu X, Zhao A, Zhu M. Davis JD, et al. Among authors: jayachandran p. Clin Pharmacol Ther. 2024 Mar;115(3):422-439. doi: 10.1002/cpt.3150. Epub 2024 Jan 10. Clin Pharmacol Ther. 2024. PMID: 38093583 Review.
Moving the Needle for Oncology Dose Optimization: A Call for Action.
Venkatakrishnan K, Jayachandran P, Seo SK, van der Graaf PH, Wagner JA, Gupta N. Venkatakrishnan K, et al. Among authors: jayachandran p. Clin Pharmacol Ther. 2024 Jun;115(6):1187-1197. doi: 10.1002/cpt.3263. Clin Pharmacol Ther. 2024. PMID: 38736240 No abstract available.
Moving the needle for oncology dose optimization: A call for action.
Venkatakrishnan K, Jayachandran P, Seo SK, van der Graaf PH, Wagner JA, Gupta N. Venkatakrishnan K, et al. Among authors: jayachandran p. CPT Pharmacometrics Syst Pharmacol. 2024 May 22. doi: 10.1002/psp4.13157. Online ahead of print. CPT Pharmacometrics Syst Pharmacol. 2024. PMID: 38778466 Free article. No abstract available.
CCR5 and CCL5 gene expression in colorectal cancer: comprehensive profiling and clinical value.
Battaglin F, Baca Y, Millstein J, Yang Y, Xiu J, Arai H, Wang J, Ou FS, Innocenti F, Mumenthaler SM, Jayachandran P, Kawanishi N, Lenz A, Soni S, Algaze S, Zhang W, Khoukaz T, Roussos Torres E, Seeber A, Abraham JP, Lou E, Philip PA, Weinberg BA, Shields AF, Goldberg RM, Marshall JL, Venook AP, Korn WM, Lenz HJ. Battaglin F, et al. Among authors: jayachandran p. J Immunother Cancer. 2024 Jan 11;12(1):e007939. doi: 10.1136/jitc-2023-007939. J Immunother Cancer. 2024. PMID: 38212126 Free PMC article.
50 results